Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sanderson

Showing results (201-210 of 387) with videos related to

Pageof 39
Sort By:
European Journal of Gastroenterology & Hepatology|June 9, 2001
Gastro-oesophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritisD K Manifold, A Anggiansah, I Rowe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regionsI B Bayer-Garner, R D Sanderson, M V Dhodapkar, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2016
Heparanase: From basic research to therapeutic applications in cancer and inflammationIsrael Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Clinical Immunology (Orlando, Fla.)|June 27, 2015
Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvantBala Vamsi K Karuturi, Shailendra B Tallapaka, Joy A Phillips, et al.
Blood|January 26, 2010
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesisAnurag Purushothaman, Toru Uyama, Fumi Kobayashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Journal of Medicinal Chemistry|March 14, 1997
Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activityA M Finch, S M Vogen, S A Sherman, et al.
The Journal of Biological Chemistry|August 26, 1998
Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functionsW Liu, E D Litwack, M J Stanley, et al.
The Journal of Biological Chemistry|July 15, 2009
Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivoYekaterina B Khotskaya, Yuemeng Dai, Joseph P Ritchie, et al.
Journal of Crohn'S & Colitis|March 6, 2012
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinolMelissa A Smith, Paul Blaker, Anthony M Marinaki, et al.
Pageof 39

Showing results (201-210 of 387) with videos related to

Sort By:
Pageof 39
European Journal of Gastroenterology & Hepatology|June 9, 2001
Gastro-oesophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritisD K Manifold, A Anggiansah, I Rowe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regionsI B Bayer-Garner, R D Sanderson, M V Dhodapkar, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2016
Heparanase: From basic research to therapeutic applications in cancer and inflammationIsrael Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Clinical Immunology (Orlando, Fla.)|June 27, 2015
Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvantBala Vamsi K Karuturi, Shailendra B Tallapaka, Joy A Phillips, et al.
Blood|January 26, 2010
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesisAnurag Purushothaman, Toru Uyama, Fumi Kobayashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptorR R Buchner, S M Vogen, W Fischer, et al.
Journal of Medicinal Chemistry|March 14, 1997
Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activityA M Finch, S M Vogen, S A Sherman, et al.
The Journal of Biological Chemistry|August 26, 1998
Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functionsW Liu, E D Litwack, M J Stanley, et al.
The Journal of Biological Chemistry|July 15, 2009
Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivoYekaterina B Khotskaya, Yuemeng Dai, Joseph P Ritchie, et al.
Journal of Crohn'S & Colitis|March 6, 2012
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinolMelissa A Smith, Paul Blaker, Anthony M Marinaki, et al.
Pageof 39